A detailed history of Aqr Capital Management LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 23,392 shares of RLAY stock, worth $98,948. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,392
Previous 67,243 65.21%
Holding current value
$98,948
Previous $438,000 62.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.23 - $9.51 $273,191 - $417,023
-43,851 Reduced 65.21%
23,392 $165,000
Q2 2024

Aug 14, 2024

BUY
$5.9 - $8.02 $310,888 - $422,597
52,693 Added 362.15%
67,243 $438,000
Q1 2024

May 15, 2024

BUY
$7.5 - $12.07 $22,867 - $36,801
3,049 Added 26.51%
14,550 $120,000
Q4 2023

Feb 14, 2024

BUY
$6.01 - $11.48 $69,121 - $132,031
11,501 New
11,501 $126,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $509M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.